WAT logo

WATERS CORP

WATNYSE
πŸ† #305 by market capEarnings Nov 3US Equity
$301.64β–² $13.94 (+4.62%)
Simulated price
1hβ€”
24hβ–² 4.6%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$37.34B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+52.5%
High Growth
πŸ“ŠGross Margin
50.9%
Healthy
πŸ’΅FCF Margin
9.5%
Moderate
βš–οΈP/S Ratio
8.6x
Elevated
Otter Score
64
Fair
No chart data available for WAT.

Trading Snapshot

Day Range
$300.65 – $305.36
52-Week Range
$275.05 – $414.15
Volume
$5.68B
Avg Volume
$6.25B
Shares Outstanding
98.2M
Next Earnings
Oct 17, 2026

Fundamentals Snapshot

Annual Revenue
$3.17B
Last Q Revenue
$1.65B
P/E Ratio
240.5
P/S Ratio
8.6x
EPS (TTM)
$4.00
Dividend Yield
β€”

Why Investors Own WAT

  • βœ“High-growth profile β€” revenue up +21.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 39% gross margin and 8% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$3.17Bβ–² +19.2% YoY
Gross Margin (TTM)
38.6%β–Ό βˆ’0.5% YoY
Operating Income (TTM)
$313Mβ–² +19.2% YoY
Free Cash Flow (TTM)
$250Mβ–² +19.2% YoY

About WATERS CORP

Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$390.59
β–² +29.5% Upside
High Target$445.89
Low Target$328.77
Based on 29 analysts

Latest News & Updates